Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation. Ting YT, Ooi JD. Kidney Int 2026 Feb 12:S0085-2538(26)00070-0. doi: 10.1016/j.kint.2026.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ting YT, Ooi JD. Hybrid CARs: rewiring macrophage signaling for targeted therapy in acute and chronic kidney inflammation. Kidney Int 2026 Feb 12:S0085-2538(26)00070-0. doi: 10.1016/j.kint.2026.
PMID: 41722614